phase readout
saveNCT06267001: A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy
COMPLETEDupdated 2mo ago
community read0 votes
Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer (NSCLC)
view source ↗
comments(0)
5-min edit window · permanent after that